Loading clinical trials...
Loading clinical trials...
This is a multi-center, open-label, 52-week safety and tolerability study of plecanatide in patients with Chronic Idiopathic Constipation (CIC).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bausch Health Americas, Inc.
Collaborators
NCT04838522 · Chronic Idiopathic Constipation (CIC)
NCT06736912 · Chronic Idiopathic Constipation
NCT03879239 · Chronic Idiopathic Constipation
NCT04804267 · Chronic Idiopathic Constipation
NCT02819297 · Constipation, Chronic Idiopathic Constipation, and more
Synergy Research Site
Birmingham, Alabama
Synergy Research Site
Dothan, Alabama
Synergy Research Site
Gulf Shores, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions